Partner Fund Management Has Confidence In Blueprint Medicines Corp (BPMC)

Page 11 of 13 – SEC Filing

CUSIP No. 09627Y109

13G

Page 11 of 13 Pages

C.

Brian D. Grossman

(a)

Grossman may be deemed to beneficially own 1,378,734 shares of Common Stock.

(b)

The number of shares Grossman may be deemed to beneficially own constitutes approximately 5.1% of the Common Stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 1,378,734

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 1,378,734

D.

Christopher M. James

(a)

James may be deemed to beneficially own 1,378,734 shares of Common Stock.

(b)

The number of shares James may be deemed to beneficially own constitutes approximately 5.1% of the Common Stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 1,378,734

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 1,378,734

 

Item 5	Ownership of Five Percent or Less of a Class
	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨.
Item 6	Ownership of More than Five Percent on Behalf of Another Person
	Not Applicable
Item 7	Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company
	See Item 2 above
Item 8	Identification and Classification of Members of the Group
	Not Applicable

 

Follow Blueprint Medicines Corp (NASDAQ:BPMC)

Follow Blueprint Medicines Corp (NASDAQ:BPMC)

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.